Oxurion
0 followers
Oxurion (Euronext Brussels: OXUR - formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diab... Read more
Org chart
Andy De Deene
Chief Development Officer
Grace Chang
Chief Medical Officer
Kathleen Paisley
Chief Legal Officer & General Counsel
Philippe B.
Chief Scientific Officer
An Huysmans
Finance Director And Corporate Controller
Alfred Aronson
Director Human Resources
Linda Knott
Assistant To US Corporate Team
